As an active pharmaceutical ingredient (API) manufacturer, Vantage prepares for its DMF submissions to the FDA to support the quality and safety of its products.
The demand for cannabidiol (CBD) is growing fast in the pharmaceutical sector, thanks to increased awareness among consumers about CBD health benefits.
Vantage is a global leader in the production of CBD extracts with its facilities achieving ICH Q7 and WHO Good Manufacturing Practices (GMP) certification.